SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-002358
Filing Date
2017-09-13
Accepted
2017-09-12 20:34:53
Documents
61
Period of Report
2017-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-073117.htm 10-Q 353572
2 CERTIFICATION pharm_ex3101.htm EX-31.1 8958
3 CERTIFICATION pharm_ex3102.htm EX-31.2 8881
4 CERTIFICATION pharm_ex3201.htm EX-32.1 4303
5 CERTIFICATION pharm_ex3202.htm EX-32.2 4444
  Complete submission text file 0001683168-17-002358.txt   2871300

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20170731.xml EX-101.INS 552408
7 XBRL SCHEMA FILE pmcb-20170731.xsd EX-101.SCH 34149
8 XBRL CALCULATION FILE pmcb-20170731_cal.xml EX-101.CAL 39810
9 XBRL DEFINITION FILE pmcb-20170731_def.xml EX-101.DEF 153388
10 XBRL LABEL FILE pmcb-20170731_lab.xml EX-101.LAB 243034
11 XBRL PRESENTATION FILE pmcb-20170731_pre.xml EX-101.PRE 219730
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 171082086
SIC: 2833 Medicinal Chemicals & Botanical Products